Clinical Trials Browser

Phase EARLY_PHASE1 × Imiquimod × Dermatologic × Clear all

NCT03276832 2026-03-19

Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma

Phase EARLY_PHASE1 Completed

7 enrolled 11 charts

Melanoma

NCT03116659 2019-08-13

CTCL Directed Therapy

Phase EARLY_PHASE1 Unknown

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous